BDBM358992 (6R,8aS)-6-[8-amino-5- chloro-1-(4-{(1R)-1- hydroxy-1-[3-(2,2,2- trifluoro-1,1- dimethylethyl)phenyl] ethyl}phenyl)imidazo[1, 5-a]pyrazin-3- yl]hexahydroindolizin- 3(2H)-one::US10214546, Example 124

SMILES CC(C)(c1cccc(c1)[C@](C)(O)c1ccc(cc1)-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2c(Cl)cnc(N)c12)C(F)(F)F

InChI Key InChIKey=OGJFQBSPONRXOY-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 358992   

TargetTyrosine-protein kinase BTK(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM358992((6R,8aS)-6-[8-amino-5- chloro-1-(4-{(1R)-1- hydrox...)
Affinity DataIC50: 1.20nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/20/2019
Entry Details
US Patent